SENSEX
NIFTY
GOLD
USD/INR

Weather

image 27    C

Health & Fitness News

The Economic Times

Health & Fitness / The Economic Times

details

Aurobindo Pharma launches generic Advair Diskus for asthma and COPD in US

Lannett Company, part of Aurobindo Pharma, has launched generic Advair Diskus in the US, making it the first complex inhalation product from Aurobindo to be marketed there. This market is worth approximately $908 million. Moreover, Cipla's US branch has also obtained FDA approval for the same product, setting the stage for an exciting competition in respiratory treatments.

31 Aug 2026 6:18 pm